Oramed, Biotech Stock REview

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

New technology could revolutionize market of 500 million diabetes patients (i24 News).
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.
video

Candida Auris: Hospitals mobilize to fight the deadly infection (Video). More Videos Below.

https://youtu.be/hnqFdKSG6-A Auris all over the room, even on the ceiling?.

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly Higher on News.

Fortress Bio (FBIO, $2.42) Up 43%, Citius Pharma (CTXR, $1.15) Up 109% and True Nature Holdings (TNTY, $0.043) Up 117%, Since Adding...
Julie R Smith, True Nature, Mitesco

True Nature|Mitesco President & COO, Julie Smith Interview.

Julie R. Smith is a seasoned senior executive...

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
steven boyd, biotech stock review

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

April 2019 Offering On April 1, 2019, Citius entered into securities purchase agreements with institutional investors and accredited investors...

Bellus Health (BLUSF) to Present at SF Stock & Bond Club.

Presenter: Roberto Bellini - President and Chief Executive Officer See you there, 5:30 tonight. Roberto Bellini...
Biotech Stock Review,

Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.

Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner...
biotech stock review

7 Million Telehealth Users This Year, Expected to Drive Revenues to $36 Billion in...

As boomers age, experts predict the telehealth market will grow from a $14.3 billion industry in 2013 to a $36.2 billion...

Latest article

Immunomedics, Biotech Stock Review

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.

Our First Newsletter of 2020, We Come out Swinging! Yes, you read it right. Five of our favorite...
Citius Pharmaceutical, CTXR, Biotech Stock Review

Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...
Oramed, Biotech Stock REview

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

New technology could revolutionize market of 500 million diabetes patients (i24 News).